Đang chuẩn bị liên kết để tải về tài liệu:
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Esophageal sarcomatoid carcinoma (ESC) is a rare disease with a mixture of both carcinomatous and sarcomatous components in the tumor. Its genetic background and mechanisms of oncogenesis remain largely unknown. | Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

TÀI LIỆU LIÊN QUAN

TarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma

Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients

SeqCNV: A novel method for identification of copy number variations in targeted next-generation sequencing data

ATRAM - automated target restricted assembly method: A fast method for assembling loci across divergent taxa from next-generation sequencing data

MPD: Multiplex primer design for nextgeneration targeted sequencing

Characterization of background noise in capture-based targeted sequencing data

Comparing variant calling algorithms for target-exon sequencing in a large sample

DeviCNV: Detection and visualization of exon-level copy number variants in targeted next-generation sequencing data
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.